Insights into cell movement likely to aid immune study, cancer research

Scientists at Washington University School of Medicine in St. Louis have used yeast cells to better understand a collection of proteins associated with the formation of actin networks, which are essential to cell movement.

The cell's ability to move is important to a broad range of biomedical concerns, including understanding how immune system cells pursue disease-causing invaders and how metastasizing cancer cells migrate from a tumor.

"One of the bad things that cancer cells do is to walk away from where they're supposed to be," says senior author John Cooper, M.D., Ph.D., professor of cell biology and physiology. "If they didn't walk away, cancer would be something that you could just cut out, and that would be the end of it. So one hope is that if we learn more about how cancer cells are moving, we can someday try to block that process."

The study appears this month in Public Library of Science Biology.

In yeast, the proteins Cooper's lab studied regulate actin networks' contributions to a process called endocytosis. Yeast cells use this process to take in materials from their surface by forming pits on their cell membrane. Actin networks provide the push that forms these pits and drives them into the cell.

In more complex cells like those found in humans, the proteins have additional responsibilities that include helping regulate a process that cells use to thrust themselves forward. That process assembles many thin branching filaments of a polymer, actin, on the cell's surface. As these growing filaments reach nearby structures, they exert force that propels the cell in the desired direction.

Scientists know all the ingredients of actin networks, but they don't fully understand how the cell regulates their construction.

"One of the critical steps in generating an actin network is generating the seed of a new filament," says first author Brian Galletta, Ph.D., a postdoctoral scholar in Cooper's lab. "Scientists have identified a protein complex that can do this called Arp2/3."

Cooper's lab and others also had found several proteins that regulate Arp2/3 activity. In yeast, whose complete genetic code has been sequenced and can be searched, there appears to be a total of six proteins that activate or deactivate Arp2/3. These proteins are regularly found in actin patches on the surfaces of yeast cells, which are areas where endocytosis is about to take place.

"We wanted to know why there needed to be six of these proteins, if any one could either turn Arp2/3 on or off," says Galletta.

To learn more, Galletta mutated each of the six proteins alone and in various combinations. Researchers also attached two different fluorescent labels to other proteins involved in the early and late stages of endocytosis. The labels let them use a light microscope to make movies of hundreds of actin patches in the various yeast lines, recording the patches' movement across cell membranes and into cells.

With the help of a computerized tracking program from Anders Carlsson, Ph.D., professor of physics at Washington University, they quantitatively analyzed the results, uncovering both dramatic and subtle variations in actin patch activity caused by the mutations.

"We found that sometimes the Arp2/3 regulatory proteins had a unique function of their own, and sometimes they cooperated," Galletta says. "That was surprising, because in the test tube, all of these proteins have very similar functions."

In addition to actin networks' use by immune cells chasing invading microorganisms, those same microorganisms sometimes hijack the actin networks in host cells, effectively seizing the cells' steering wheels and driving them around. The networks also play important roles in the developing embryo, enabling cells to assume specialized shapes or migrate to where they need to be in the body.

Cooper notes that a powerful regulator of Arp2/3 is mutated in a rare human disorder, Wiskott-Aldrich syndrome(WAS). Mutations in the protein, known as WAS protein, lead to autoimmune problems, eczema, increased risk of cancer and a variety of other symptoms. Humans have multiple versions of this protein, but yeast only has one, allowing Cooper's research to potentially provide guidance for scientists working to develop treatments for WAS.

Cooper plans further study of how yeast cells regulate and use actin networks. His lab is also looking at how Arp2/3 regulatory proteins contribute to function in mammalian immune system cells and cancer cells.

Source: Washington University

Related stories:

Using a light touch to measure protein bonds
MIT researchers have developed a novel technique to measure the strength of the bonds between two protein molecules important in cell machinery: Gently tugging them apart with light beams.
Understanding the migration of cancer cells
Activity of regulatory proteins for the growth of filopodia and lamelopodia clarified
Lamellipodia are veil-shaped protrusions of the plasma membrane, that can turn into upward-curled ruffles if they fail to adhere to the substrate. A dendritic meshwork of short and highly branched actin filaments might constitute their main structural component. The other type of protrusion, the filopodia, are finger-like and consist of parallel, long and unbranched actin filaments. Interestingly, fast-crawling cells mainly form lamellipodia/ruffles while poorly migrating or non-motile cells often show the coexistence of both lamellipodial and filopodial protrusions. These observations suggest that the lamellipodia-to-filopodia selection might regulate cell migration. Moreover, the pivotal contribution of lamellipodial and filopodial protrusions to important developmental and homeostatic processes certainly requires tight regulatory mechanisms.
Cell surface receptors are all 'talk' in T cell stimulation
Understanding the mechanisms that drive healthy immune responses is important when it comes to combating autoimmune diseases, which occur when cells that should attack invading organisms turn on the body instead.
Researchers discover 'modus operandi' of heart muscle protein
Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called leiomodin (Lmod) promotes the assembly of an important heart muscle protein called actin. What’s more, Lmod directs the assembly of actin to form the pumping unit of the heart. The findings appear in this week’s issue of Science.
Newly defined signaling pathway could mean better biofuel sources
A newly defined biochemical pathway in plants may provide the scientific tools to design plants that will yield larger quantities of alternative transportation fuels than currently can be produced, according to Purdue University researchers.
How red blood cells nuke their nuclei
Unlike the rest of the cells in your body, your red blood cells lack nuclei. That quirk dates back to the time when mammals began to evolve. Other vertebrates such as fish, reptiles, and birds, have red cells that contain nuclei that are inactive. Losing the nucleus enables the red blood cell to contain more oxygen-carrying hemoglobin, thus enabling more oxygen to be transported in the blood and boosting our metabolism.
Scientists find new genetic mutation that halts the development of lupus
The new study was published in the January 18 edition (Volume 28, Issue 1) of the journal Immunity.
Researchers find new way to block destructive rush of immune cells
Researchers have found a way to selectively block the ability of white blood cells to “crawl” toward the sites of injury and infection when such mobility drives disease, according to a study published today in The Journal of Experimental Medicine. The results suggest a new treatment approach for autoimmune diseases like rheumatoid arthritis, lupus and multiple sclerosis, and for conditions made worse by misplaced inflammation, like atherosclerosis, stroke and transplant rejection, researchers said.

News discussion:

Medicine & Health news